Centene Corporation (CNC)
Centene's Gold Card Push Could Ease Costs - But Will Savings Follow?
Centene's nationwide Gold Card program aims to streamline prior authorization and cut administrative costs, but adoption and actual savings will determine its financial impact.
Centene vs. Molina: Which Managed Care Stock Has More Upside?
CNC's diversified business, improving margins and lower valuation give it an edge over MOH, with stronger earnings prospects and greater upside potential.
Centene Q3 2026 Preview: The Quarter Is Easy, The 2027 Bridge Is Not
Centene Corporation has rebounded sharply, with shares up 73% in a year, but now trades near fair value. I expect a Q3 adjusted EPS beat (~$0.25 vs. $0.07–$0.10 consensus), but I see limited upside as 2027 earnings normalization remains the key debate. Medicaid improvement is crucial; HBR progress and membership declines must be closely monitored as policy risks and cost trends remain material.
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
CNC's improving Medicaid margins, stronger Marketplace profitability and earnings recovery support its valuation, but sustainability remains the key test.
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
PWR, FORM, SMTC, CNC and ROKU offer strong growth prospects in Q4, driven by AI demand, estimate gains, healthcare momentum and streaming growth.
Are Investors Undervaluing Centene (CNC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline Deepens
Centene NYSE: CNC reaffirmed its 2026 adjusted diluted earnings-per-share guidance of more than $4.80 at the Deutsche Bank Healthcare Summit, with Chief Executive Officer Sarah London saying the company's performance through the first two months of the third quarter was in line with expectations.
Is Centene (CNC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for September 18th
SNDR, NESR and CNC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 18th, 2026.
Can Centene Sustain Its Turnaround Amid Membership Pressure?
CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.
Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy?
Centene's diversified market presence, cash generation and recent share gains give it an edge over Oscar Health as ACA insurers target long-term growth.
